✦ LIBER ✦

Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck

✍ Scribed by Peter E. Maxim; Robert W. Veltri

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 761 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860115)57:2<305::aid-cncr2820570219>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second primary tumors in patients with h

Second primary tumors in patients with head and neck squamous cell carcinoma

✍ Eliezer Robinson; Alfred I. Neugut; A. S. Jones 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Efficacy of neck treatment in patients w

Efficacy of neck treatment in patients with head and neck squamous cell carcinoma

✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Treatment of the neck in patients with s

Treatment of the neck in patients with squamous cell carcinoma of the head and neck

✍ Richard H. Jesse; Gilbert H. Fletcher 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

Investigation of urinary transforming gr

Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck

✍ Mary Fazekas-May; Dr. James Y. Suen; Yun Chi Yeh; Hsing Wu Yeh; Lynda Beth Milli 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

## Abstract The objective of this study was to determine whether transforming growth factor alpha (TGF alpha) levels could be used as nonspecific tumor markers in patients with advanced squamous cell carcinoma (SCC) of the head and neck. Fourteen patients with epidermoid carcinoma of the head and n

Galectins as modulators of tumor progres

Galectins as modulators of tumor progression in head and neck squamous cell carcinomas

✍ Sven Saussez; Isabelle Camby; Gerard Toubeau; Robert Kiss 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

## Abstract Head and neck squamous cell carcinomas (HNSCCs) remain a significant cause of morbidity worldwide. Biological therapies able to induce and/or upregulate antitumor immune responses could represent a complementary approach to conventional treatments for patients with HNSCC because, despit

Immunoglobulin allotypes in patients wit

Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck

✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant